Today on in-pharmatechnologist.com   Almirall takes on big pharma in COPD Pfizer plans more off-shoring and outsourcing Boehringer boosts biopharma base Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline OctoPlus feels the market pressure

Related Industry News   Pharmaceutical outsourcing: people on the move Private equity firm puts crores into Indian CRO Xenome and Amylin team up to poison metabolic diseases Preclinical services news in brief

		In association with
Breaking News on Pharmaceutical Technology
Daily  Monday 03 December 2007		Forward to a colleague

	Application Note Reproducible, homogeneous dry dispersions by the Morphologi® G3's integrated SDU enabling reduced measurement times The Morphologi® G3 automated particle characterization system from Malvern® Instruments is a new analytical tool that provides high quality, statistically significant particle size and shape information... Click Here Access Full Stories Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Pfizer plans more off-shoring and outsourcing Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs... Read Boehringer boosts biopharma base Boehringer Ingelheim has completed a hefty makeover of its biopharmaceutical production plant in Biberach, Germany... Read Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron... Read OctoPlus feels the market pressure Dutch drug delivery and development company OctoPlus is withdrawing its follow-on financing on its five-strong product portfolio in response to the US mortgage crisis and the struggling stock market... Read
	All News Headlines for: December | November | October
	Application Note Transdermal Sufentanil Licensing Opportunity Aveva's 7-day sufentanil's advanced technology and patient benefits will enable Aveva and its Partner to capture a significant share of the existing $3.9 billion dollar chronic pain market... Click Here
	Related Industry News Pharmaceutical outsourcing: people on the move Patheon, Parexel, and others have all had people on the move in the world of pharmaceutical outsourcing... Read Private equity firm puts crores into Indian CRO GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read Xenome and Amylin team up to poison metabolic diseases Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read Weekly Comment No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read Event Info Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here Previous Headlines Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read Jubilant Organosys eyeing up European acquisitions Indian pharma services provider Jubilant Organosys is looking to buy up European contract research organisations (CRO) and contract research and manufacturing services (CRAMS) and it has got $100m to spend, according... Read Merck heads to Ireland for new 200m site Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island... Read A spoonful of foam helps the medicine go down Is it a liquid? Is it a solid?.........No, it's 'foam-on-a-spoon'... Read Akorn and Cipla team up again Specialty pharmaceutical company Akorn has signed up with India-based Cipla in an exclusive manufacturing and supply agreement for an undisclosed inhaled drug... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Product Information - brochures, Web centers The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com